at Duke University in North Carolina. However, validation in larger datasets is necessary before it can be used in clinical settings, he says.
“Obviously, this is not a full list of every single infectious and inflammatory disease out there,” says Kaforou. “At the moment, we are recruiting more patients and generating more data to identify a signature that covers even more infectious and inflammation conditions.”
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: